MacRae, Rob <br/><br/>
Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant.  [electronic resource] 

 -  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology  Jul 2002 
 - 37-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-8140 
<br/><br/><label>Standard No.: </label>10.1016/s0167-8140(02)00151-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anemia--chemically induced<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Combined Modality Therapy<br/>Female<br/>Hemoglobins--analysis<br/>Humans<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Paclitaxel--administration & dosage<br/>Prognosis<br/>Radiotherapy--adverse effects<br/>Retrospective Studies<br/>Survival Rate